Intrinsic Value of S&P & Nasdaq Contact Us

The Cooper Companies, Inc. COO NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
66/100
4/7 Pass
SharesGrow Intrinsic Value
$111.59
+55.8%
Analyst Price Target
$93.86
+31.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

The Cooper Companies, Inc. (COO) trades at a trailing P/E of 34.6, forward P/E of 15.5. Trailing earnings yield is 2.89%, forward earnings yield 6.45%. PEG 0.11 (Peter Lynch undervalued ≤1.0). Graham Number is $44.19.

Criteria proven by this page:

  • VALUE (36/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Forward P/E 15.5 (down from trailing 34.6) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.11 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 2.89% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 6.45% as earnings recover.
  • Analyst consensus target $93.86 (+31.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 66/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
66/100
SG Score
View full scorecard →
VALUE
36/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
71/100
→ Income
~
GROWTH
55/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — COO

Valuation Multiples
P/E (TTM)34.6
Forward P/E15.5
PEG Ratio0.11
Forward PEG0.11
P/B Ratio1.66
P/S Ratio3.32
EV/EBITDA16.8
Per Share Data
EPS (TTM)$2.04
Forward EPS (Est.)$4.62
Book Value / Share$42.52
Revenue / Share$21.11
FCF / Share$2.50
Yields & Fair Value
Earnings Yield2.89%
Forward Earnings Yield6.45%
Dividend Yield0.00%
Graham Number$44.19
SharesGrow IV$111.59 (+55.8%)
Analyst Target$93.86 (+31.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 31.2 0.90 3.17 4.34 0.03%
2017 31.5 0.90 3.70 5.49 0.02%
2018 90.7 -1.45 3.83 5.01 0.02%
2019 30.7 0.13 3.95 5.41 0.02%
2020 65.7 -1.35 4.10 6.44 0.02%
2021 7.1 0.01 3.00 7.12 0.01%
2022 34.9 -0.36 1.88 4.07 0.02%
2023 52.5 -2.19 2.04 4.29 0.02%
2024 53.1 1.65 2.58 5.34 -
2025 37.3 -8.16 1.70 3.42 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $5.59 $1.97B $273.92M 13.9%
2017 $7.52 $2.14B $372.9M 17.4%
2018 $2.81 $2.53B $139.9M 5.5%
2019 $2.33 $2.65B $466.7M 17.6%
2020 $1.20 $2.43B $238.4M 9.8%
2021 $14.78 $2.92B $2.94B 100.8%
2022 $1.94 $3.31B $385.8M 11.7%
2023 $1.48 $3.59B $294.2M 8.2%
2024 $1.96 $3.9B $392.3M 10.1%
2025 $1.87 $4.09B $374.9M 9.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $4.62 $4.58 – $4.66 $4.32B $4.31B – $4.33B 11
2027 $5.03 $4.92 – $5.10 $4.55B $4.53B – $4.59B 11
2028 $5.45 $4.88 – $6.17 $4.79B $4.79B – $4.79B 6
2029 $5.96 $5.91 – $6.02 $5.03B $5B – $5.07B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message